NNovartis Read More Sub-Saharan Africa | Novartis2026-11-10 Why does Novartis work in sub-Saharan Africa? Sub-Saharan Africa is home to some of the world’s fastest growing…
NNovartis Read More Novartis ranks first place in 2026 Access to Medicine2026-11-10 Novartis retains first place ranking among 20 sector peers for efforts to improve access to medicinesFirst company to…
NNovartis Read More Novartis ranks No. 1 in 2026 Access to Medicine Index2026-11-10 Breakthroughs only matter when you break down barriers to healthcare. In 2025, our medicines reached 300 million patients,…
NNovartis Read More Fortune includes Novartis in 2026 Change The World List for malaria program2026-09-23 Novartis has been named to Fortune’s Change the World 2026 list in recognition of our malaria program, one…
NNovartis Read More Novartis Antimalarial Clears Key WHO Review to Get the Combo Drug to Babies2026-04-26 The first antimalarial developed specifically for babies is a step closer to reaching parts of the world where…
NNovartis Read More Novartis malaria treatment Coartem® Baby receives WHO prequalification2026-04-26 Novartis malaria treatment Coartem® Baby receives WHO prequalification April 26, 2026 | Sunday | News Coartem® (artemether-lumefantrine) Baby…
NNovartis Read More Novartis malaria treatment Coartem® Baby receives WHO prequalification, paving way for greater access for newborns and young infants2026-04-24 Coartem® (artemether-lumefantrine) Baby is the first and only malaria treatment for newborns and young infants, closing long-standing treatment…
NNovartis Read More Vas Narasimhan on his rise to Novartis CEO2026-03-16 Guided by immigrant roots, public‑health purpose and a belief in “staying in the ring,” Novartis CEO Vas Narasimhan…
NNovartis Read More Turning personal experience into purpose-driven careers2026-03-10 For Arti, Giselle and Maria their desire for purpose began with a moment that changed everything and grew…
GGeneva Read More Global Fund boss warns aid cuts jeopardise progress against malaria2026-03-08 Climate change, conflicts and a lack of funding compounded by recent aid cuts are hurting hard-won gains in…
NNovartis Read More Breaking ground in Global Health2026-02-25 This past year has been active at Novartis in the malaria space. What has it meant for your…
NNovartis Read More Novartis receives approval for first malaria medicine for newborn babies and young infants2026-02-13 Coartem® (artemether-lumefantrine) Baby becomes first malaria treatment approved for newborn babies and young infants Rapid approvals in eight…